Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Sanders

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Annual Review of Microbiology|January 1, 1987
Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibioticsC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1992
Review of preclinical studies with ofloxacinC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolonesC C Sanders
Antimicrobial Agents and Chemotherapy|December 1, 1981
Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzaeC C Sanders
The Journal of Antimicrobial Chemotherapy|November 1, 1991
ARTs versus ASTs: where are we going?C C Sanders
Antimicrobial Agents and Chemotherapy|August 1, 1977
Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycinC C Sanders
The Journal of Infectious Diseases|March 1, 1983
Novel resistance selected by the new expanded-spectrum cephalosporins: a concernC C Sanders
The Journal of Infectious Diseases|March 1, 1986
Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescensC C Sanders, C Watanakunakorn
Antimicrobial Agents and Chemotherapy|November 1, 1989
ampG is essential for high-level expression of AmpC beta-lactamase in Enterobacter cloacaeG Korfmann, C C Sanders
Reviews of Infectious Diseases|July 1, 1988
Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporinsW E Sanders, C C Sanders
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Annual Review of Microbiology|January 1, 1987
Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibioticsC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1992
Review of preclinical studies with ofloxacinC C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolonesC C Sanders
Antimicrobial Agents and Chemotherapy|December 1, 1981
Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzaeC C Sanders
The Journal of Antimicrobial Chemotherapy|November 1, 1991
ARTs versus ASTs: where are we going?C C Sanders
Antimicrobial Agents and Chemotherapy|August 1, 1977
Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycinC C Sanders
The Journal of Infectious Diseases|March 1, 1983
Novel resistance selected by the new expanded-spectrum cephalosporins: a concernC C Sanders
The Journal of Infectious Diseases|March 1, 1986
Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescensC C Sanders, C Watanakunakorn
Antimicrobial Agents and Chemotherapy|November 1, 1989
ampG is essential for high-level expression of AmpC beta-lactamase in Enterobacter cloacaeG Korfmann, C C Sanders
Reviews of Infectious Diseases|July 1, 1988
Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporinsW E Sanders, C C Sanders
Pageof 16